✦ LIBER ✦

Chemoradiation With Paclitaxel and Carboplatin in High-Risk Cervical Cancer Patients After Radical Hysterectomy: A Korean Gynecologic Oncology Group Study

✍ Scribed by Lee, Taek Sang; Kang, Soon Beom; Kim, Young Tak; Park, Byung Joo; Kim, Yong Man; Lee, Jong Min; Kim, Seok Mo; Kim, Young Tae; Kim, Jae Hoon; Kim, Kyung Tai

Book ID: 122559397
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 265 KB
Volume: 86
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2013.01.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent chemoradiation with paclitaxe

Concurrent chemoradiation with paclitaxel in high-risk endometrial cancer patients after surgery: A Korean Gynecologic Oncology Group study

✍ Hwang, S.M.; Cho, H.; Chay, D.B.; Kim, S.; Kim, J.H. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 54 KB

A Phase 2 Trial of Radiation Therapy Wit

A Phase 2 Trial of Radiation Therapy With Concurrent Paclitaxel Chemotherapy After Surgery in Patients With High-Risk Endometrial Cancer: A Korean Gynecologic Oncologic Group Study

✍ Cho, Hanbyoul; Nam, Byung-Ho; Kim, Seok Mo; Cho, Chi-Heum; Kim, Byoung Gie; Ryu, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 345 KB

Phase I feasibility trial of carboplatin

Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study

✍ Katherine Y Look; Michael A Bookman; Jessie Schol; Thomas J Herzog; Thomas Rocer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

771 Paclitaxel and carboplatin as adjuva

771 Paclitaxel and carboplatin as adjuvant treatment in high-risk patients with operable non-small cell lung cancer (NSCLC): A feasibility study conducted by the hellenic cooperative oncology group (HeCOG)

✍ H. Timotheadou; Ch. Christodoulou; Ch. Papakonstantinou; S. Papadopoulos; J. Skr 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

A phase I trial of dose-dense (biweekly)

A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: A feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: A Gynecologic Oncology Group study

✍ Amy D. Tiersten; Michael W. Sill; Danielle Knight; Franco Muggia; Agustin A. Gar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 226 KB

1A randomized phase III trial of pelvic

1A randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk (HR), early stage endometrial cancer (EC): A Gynecologic Oncology Group trial

✍ McMeekin, D.S.; Filiaci, V.L.; Aghajanian, C.; Cho, J.; Kim, J.W.; DiSilvestro, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 102 KB